Insights & News

Pharmaceutical Manufacturing Insights | Saar Biotech Articles

Expert insights on third-party manufacturing, specialty formulations, and scalable B2B growth strategies from Saar Biotech.

Haryana's New Pharma Policy: Another State Enters the Manufacturing Race — What It Means for Baddi Featured Insight
Industry Insights 5 min read

Haryana's New Pharma Policy: Another State Enters the Manufacturing Race — What It Means for Baddi

Every few years, another Indian state announces an ambitious pharma manufacturing policy. Haryana’s latest is a serious one on paper — but it’s worth understanding what …

Haryana's New Pharma Policy: Another State Enters the Manufacturing Race — What It Means for Baddi
Industry Insights Aug 11, 2026

Haryana's New Pharma Policy: Another State Enters the Manufacturing Race — What It Means for Baddi

Every few years, another Indian state announces an ambitious pharma manufacturing policy. Haryana’s …

The Shift Toward Specialty Manufacturing: Should Your Brand Diversify Beyond Standard Generics?
Industry Insights Aug 07, 2026

The Shift Toward Specialty Manufacturing: Should Your Brand Diversify Beyond Standard Generics?

Large pharma companies are responding to margin pressure by pouring capital into oncology and biosimilars. …

Why Pharma Quality Concerns Keep Making Headlines — And What It Means for Choosing a Manufacturer
Quality Assurance Aug 04, 2026

Why Pharma Quality Concerns Keep Making Headlines — And What It Means for Choosing a Manufacturer

Quality concerns around Indian pharmaceutical manufacturing surface in the news with some regularity — and …

Nutraceutical & Vitamin D3 Manufacturing in India: The Pharma-Nutra Crossover Opportunity
Product Manufacturing Jul 31, 2026

Nutraceutical & Vitamin D3 Manufacturing in India: The Pharma-Nutra Crossover Opportunity

Somewhere between “pharmaceutical” and “FMCG wellness product” sits one of the …

PLI Scheme for Pharmaceuticals Explained: What It Means for Indian API Sourcing and Pricing
Regulatory & Compliance Jul 28, 2026

PLI Scheme for Pharmaceuticals Explained: What It Means for Indian API Sourcing and Pricing

If you’ve sourced pharma products from India for any length of time, you’ve likely felt the …

Nasal Spray Contract Manufacturing in India: A Specialist's Guide
Product Manufacturing Jul 24, 2026

Nasal Spray Contract Manufacturing in India: A Specialist's Guide

Nasal sprays occupy an unusual position in the Indian pharma contract manufacturing landscape: everyone agrees …

Complete Guide for Schedule M Compliance in Pharma: 2026 GMP Upgrades
Regulatory & Compliance Jul 21, 2026

Complete Guide for Schedule M Compliance in Pharma: 2026 GMP Upgrades

The Indian pharmaceutical landscape is undergoing a monumental shift with the implementation of the Revised …

Third-Party Syrup & Suspension Manufacturer in India: Pricing, MOQ & Process
Product Manufacturing Jul 21, 2026

Third-Party Syrup & Suspension Manufacturer in India: Pricing, MOQ & Process

If you’re building a pharma brand in India, chances are your first product isn’t a tablet — …

Sodium Alginate, Sodium Bicarbonate & Calcium Carbonate Suspension: A Deep Dive into Indian Manufacturing
Formulation Spotlight Jul 17, 2026

Sodium Alginate, Sodium Bicarbonate & Calcium Carbonate Suspension: A Deep Dive into Indian Manufacturing

Most antacid suspensions work the same simple way: neutralize acid, feel better. This formulation is …

Automation & AI in Pharma Manufacturing: What's Actually Changing on the Factory Floor
Industry Insights Jul 14, 2026

Automation & AI in Pharma Manufacturing: What's Actually Changing on the Factory Floor

Every pharma manufacturing conversation in 2026 seems to include the word “AI” somewhere — often …

What is IP 2026? India's New Pharmacopoeia Explained for Pharma Brand Owners
Regulatory & Compliance Jul 11, 2026

What is IP 2026? India's New Pharmacopoeia Explained for Pharma Brand Owners

If you’ve read any of our regulatory content, you’ve seen “IP 2026” mentioned as a …

India's Pharma Industry Set to Double by 2030: What It Means for Third-Party Manufacturers in Baddi
Industry Insights Jul 08, 2026

India's Pharma Industry Set to Double by 2030: What It Means for Third-Party Manufacturers in Baddi

The numbers are staggering — and they are real. According to the Ministry of Commerce & Industry, …

Baddi Pharma Hub 2026: Inside Asia's Largest Manufacturing Cluster
Industry Insights Jul 07, 2026

Baddi Pharma Hub 2026: Inside Asia's Largest Manufacturing Cluster

If you’re operating in the Indian pharmaceutical space, you already know the name: Baddi. Nestled in the …

How to Start Third-Party Pharma Manufacturing in India: The Complete 2026 Guide
B2B Manufacturing Jun 30, 2026

How to Start Third-Party Pharma Manufacturing in India: The Complete 2026 Guide

The Indian pharmaceutical industry processed ₹4.2 lakh crore worth of formulations in FY2024 — and more than …

Quality Control in Pharma Contract Manufacturing: A WHO-GMP Compliance Guide
Quality Assurance Jun 23, 2026

Quality Control in Pharma Contract Manufacturing: A WHO-GMP Compliance Guide

In the pharmaceutical industry, quality is not a feature—it is a legal mandate and a moral obligation. When …

Call Us
WhatsApp
Email